ClinicalTrials.Veeva

Menu

Comparative Study of Safety and Efficacy of Heavyweight and Partially Absorbable Mesh in Inguinal Hernia Repair

Samyang Biopharmaceuticals Corporation logo

Samyang Biopharmaceuticals Corporation

Status and phase

Completed
Phase 4

Conditions

Hernia, Inguinal

Treatments

Device: Proflex® Mesh Mesh implantation
Device: Marlex® Mesh Implant

Study type

Interventional

Funder types

Industry

Identifiers

NCT01877122
MS1-1004

Details and patient eligibility

About

Proflex® Mesh (partially absorbable mesh, Korea) and Marlex® Mesh (heavyweight mesh) will be used for inguinal hernia repair to compare the safety and efficacy (pain score, quality of life)of two devices at 3 months follow-up.

Enrollment

50 patients

Sex

Male

Ages

20 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Male patients >=20 years =<85 years old
  2. Patients with Unilateral hernia
  3. Patients without previous operations in lower part of abdomen
  4. Patients capable to understand the explanation about purpose and method of the trial, and write an Informed Concent Form
  5. Patients capable to participate during the period of the trial

Exclusion criteria

  1. Previous hernia repair at the same site
  2. Incarcerated hernia
  3. Strangulated hernia
  4. Patients to whom and open surgery cannot be indicated
  5. Previous urological surgery
  6. Immune incompetence of patient: AIDS, vesical fibrosis, etc.
  7. Patients with AIHD or patients who take immunosuppressive drugs
  8. Patients with liver disease (ASL, AST ≥ normal value by more than 3 times)
  9. Patients with kidney disease (creatinine>2.0mg/dL)
  10. Patients on anti-coagulants
  11. Patients with severe systematic disease
  12. Patients with malignant tumor
  13. Patients with infection or with the predicted problem of surgery site healing
  14. Participation in another clinical study within the last 30 days
  15. Patients whose participation is considered inappropriate according to other except above mentioned clinical condition

Trial design

50 participants in 2 patient groups

Proflex® Mesh
Experimental group
Description:
Device: Partially absorbable lightweight mesh Intervention: Mesh implantation
Treatment:
Device: Proflex® Mesh Mesh implantation
Marlex® Mesh
Active Comparator group
Description:
Device: Non-absorbable Heavyweight mesh Intervention: Mesh implantation
Treatment:
Device: Marlex® Mesh Implant

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems